I‐Cheng Lee
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 46
- Hepatocellular Carcinoma Treatment and Prognosis 29
- Hepatitis C virus research 19
- Epidemiology 34
- Hepatitis B Virus Studies 25
- Liver Disease Diagnosis and Treatment 23
I‐Cheng Lee
51 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Hepatology 700
- Epidemiology 557
- Oncology 285
- Infectious Diseases 153
- Cancer Research 102
Countries citing papers authored by I‐Cheng Lee
This map shows the geographic impact of I‐Cheng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Cheng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Cheng Lee more than expected).
Fields of papers citing papers by I‐Cheng Lee
This network shows the impact of papers produced by I‐Cheng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Cheng Lee. The network helps show where I‐Cheng Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I‐Cheng Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 33 | |
| 14 | 2021 | 9 | |
| 15 | 2020 | 46 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 76 | |
| 18 | 2015 | 8 | |
| 19 | 2015 | 18 | |
| 20 | 2010 | 11 |
About I‐Cheng Lee
I‐Cheng Lee is a scholar working on Hepatology, Epidemiology, Oncology, Pathology and Forensic Medicine and Surgery, having authored 57 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer Mechanisms and Therapy (7 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Hepatology (700 citations), Epidemiology (557 citations), Oncology (285 citations), Infectious Diseases (153 citations) and Cancer Research (102 citations). I‐Cheng Lee has collaborated with scholars based in Taiwan, United Arab Emirates and Malaysia. Frequent co-authors include Yi‐Hsiang Huang, Teh‐Ia Huo, Han‐Chieh Lin, Chien‐Wei Su, Ming‐Chih Hou, Yee Chao, Pei‐Chang Lee, Ya‐Wen Hung, Keng‐Hsin Lan and Ming‐Huang Chen. Their work appears in journals such as Liver Cancer, Cancers, Liver International, Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.